# Project Authenticity Check — Phase 1 Self-Audit
**Prior Authorization Intelligence System**
**Phase 1 Audit | Completed: 2026-05-31**

---

## Purpose

This document is a structured self-audit of Phase 1 deliverables. It answers the six mandatory audit questions before Phase 2 begins. The audit is written to simulate the perspective of a skeptical healthcare analytics recruiter at CVS Health, Aetna, UnitedHealthcare, or a payer analytics consulting firm reviewing this portfolio project.

---

## Audit Question 1: Are All Sources Real and Relevant?

### Verdict: ✅ YES — All sources verified as real, publicly accessible, and directly relevant.

| Source ID | Source | Real? | Accessible? | Relevant? | Notes |
|-----------|--------|-------|------------|-----------|-------|
| S1 | CMS-0057-F Final Rule | ✅ | ✅ | ✅ | Published January 17, 2024. PDF available at cms.gov. Primary regulatory anchor. |
| S2 | CMS-0057-F Fact Sheet | ✅ | ✅ | ✅ | Published January 2024. Direct CMS implementation guidance. |
| S3 | KFF MA PA Analysis 2024 | ✅ | ✅ | ✅ | Published 2025, covers CY2024 CMS data. Specific statistics cited with correct figures. |
| S4 | KFF MA PA Analysis 2023 | ✅ | ✅ | ✅ | Published 2024, covers CY2023 CMS data. Used for YoY trend. |
| S5 | HHS OIG Report OEI-09-18-00260 | ✅ | ✅ | ✅ | Published 2022. Key finding (13% of denials met coverage rules) is from actual OIG methodology. Study period June 2019; acknowledged in benchmarks. |
| S6 | HHS OIG Medicaid Managed Care PA Report 2023 | ✅ | ✅ | ✅ | Published 2023. Extends OIG findings to Medicaid context. |
| S7 | Aetna/CVS Health PA Simplification Press Release | ✅ | ✅ | ✅ | Published on cvshealth.com and investors.cvshealth.com. Figures (88%, 95%, 83%) verified. |
| S8 | AMA Prior Authorization Physician Survey 2025 | ✅ | ✅ | ✅ | Published at ama-assn.org. Survey methodology documented. Figures (39 PAs/week, 13 hrs/week) verified. |
| S9 | CMS Press Release on CMS-0057-F | ✅ | ✅ | ✅ | Official CMS newsroom. Corroborates S1. |
| S10 | CMS MA/Part D Enrollment Data | ✅ | ✅ | ✅ | CMS public use data hub. Active and updated annually. |

**No sources are invented, dead links, or loosely cited. All figures in benchmark assumptions trace back to a specific source ID.**

---

## Audit Question 2: Does Every Source Support the Project Directly?

### Verdict: ✅ YES — Each source serves a specific, named project function.

| Source | Direct Project Function |
|--------|------------------------|
| S1 (CMS-0057-F) | Regulatory mandate context; decision timeframe SLA thresholds (72hr/7day); required public metrics list; API timeline |
| S2 (CMS Fact Sheet) | Confirms exact metric list payers must publish; compliance timeline |
| S3 (KFF 2024) | Primary MA approval rate, denial rate, appeal rate, overturn rate benchmarks |
| S4 (KFF 2023) | YoY trend benchmarks; appeal rate confirmation |
| S5 (OIG 2022) | Inappropriate denial rate (13%); denial reason analysis justification; core motivation for denial quality analytics |
| S6 (OIG Medicaid 2023) | Supports framing that denial rate variation across plans is analytically significant |
| S7 (Aetna/CVS) | Real-time processing rate; 24-hour approval rate; automation benchmark; industry-leading operational comparison |
| S8 (AMA Survey) | Provider burden data; documentation deficiency context; delay impact framing |
| S9 (CMS Press Release) | Project narrative framing; confirms CMS's own stated goals |
| S10 (CMS Enrollment Data) | Plan-level analysis framing; reference for MA contract-level reporting |

**No source is cited as decoration. Each appears because it provides a specific number, a specific requirement, or a specific framing that the project uses.**

---

## Audit Question 3: Are Any Claims Overstated?

### Verdict: ✅ NO SIGNIFICANT OVERSTATEMENTS — with three areas warranting transparent labeling.

### Claims That Are Accurate As Stated:

- "52.8 million PA determinations in Medicare Advantage in 2024" — exact KFF figure (S3) ✅
- "7.7% denied in full or in part" — exact KFF 2024 figure ✅
- "13% of MA PA denials met Medicare coverage rules" — exact OIG finding (S5) ✅
- "Only 11.5% of denied PAs are appealed" — exact KFF 2024 figure ✅
- "80.7% of appealed denials overturned" — exact KFF 2024 figure ✅
- "72 hours urgent / 7 days standard" — exact CMS-0057-F mandate ✅
- "88% of Aetna PA volume standardized" — direct Aetna/CVS press release (S7) ✅
- "39 PA requests per physician per week" — AMA survey finding (S8) ✅

### Areas Labeled As Assumptions (Not Overclaimed):

| Assumption ID | Assumption | Risk if Unlabeled | How Handled |
|--------------|-----------|-------------------|-------------|
| A10 | SLA compliance rate ~82% (standard) | Could be read as a real statistic | Labeled `confidence_level: Low-Medium` and `source_id: assumption` in CSV |
| A13 | Documentation incomplete rate ~22% | No direct public survey gives this exact figure | Labeled `Documented payer workflow assumption` in CSV; derived from OIG + AMA context |
| A14 | Pend rate ~12% | No single public source | Labeled `source_id: assumption` explicitly |

**All three assumptions are marked in the CSV with `confidence_level: Low-Medium` or `Low`, with `source_id: assumption` and clear `notes` field text. They will carry an "[ASSUMPTION]" label in any model documentation.**

### What This Project Does NOT Claim:
- Does not claim to have real payer data
- Does not claim the model approves or denies care
- Does not claim specific ROI figures for PA reform
- Does not claim the OIG's 13% figure is still current (study period was 2019; acknowledged)

---

## Audit Question 4: Are the Benchmark Assumptions Specific Enough to Guide Synthetic Data Generation?

### Verdict: ✅ YES — Benchmarks are complete and parameterized for use in a synthetic data generator.

The CSV provides 25 benchmark assumptions covering:

**Coverage check:**
- ✅ Approval rate baseline (A01: 92.3%)
- ✅ Denial rate baseline (A02: 7.7%)
- ✅ Appeal rate (A04: 11.5% of denials)
- ✅ Appeal overturn rate (A05: 80.7%)
- ✅ Inappropriate denial rate (A06: 13%)
- ✅ Standard turnaround time distribution (A07: mean 5 days, range 3-7)
- ✅ Urgent turnaround time distribution (A08: mean 1.5 days, range 0.5-3)
- ✅ Post-denial rework time (A09: mean 15 days, range 10-21)
- ✅ Documentation incomplete rate (A13: 22%)
- ✅ Pend rate (A14: 12%)
- ✅ Denial reason distribution — 5 categories with % shares summing to 100% (A15-A19)
- ✅ Submission channel split — electronic/fax/portal with % shares (A20-A22)
- ✅ Urgent request share (A23: 15%)
- ✅ Dataset scale guidance (A12: ~250K records for mid-size plan simulation)
- ✅ YoY growth rate (A25: 6%)

**Every benchmark has:** value, unit, lower/upper bounds, source ID, source year, confidence level, and notes. A Phase 2 data generator can consume this CSV directly.

**Gap identified:** Service category–level denial rates are not separately benchmarked (e.g., imaging vs. surgery vs. DME). This will need to be addressed in Phase 2 data design — use published OIG service category breakdowns where available, or label as assumption.

---

## Audit Question 5: What Would Make This Project Look Fake or Weak to a Healthcare Analytics Recruiter?

### Identified Risks and Mitigations:

| Risk | Severity | Status | Mitigation |
|------|---------|--------|-----------|
| Generic "healthcare dashboard" with no PA specificity | 🔴 High | ✅ Mitigated | Project framed specifically around PA workflow analytics and CMS-0057-F compliance metrics |
| Fake or hallucinated statistics | 🔴 High | ✅ Mitigated | Every stat traces to a named source ID in the registry |
| Overclaiming model clinical capability ("model approves/denies care") | 🔴 High | ✅ Mitigated | Explicit framing: models are decision-support tools only |
| No regulatory grounding | 🔴 High | ✅ Mitigated | CMS-0057-F is the backbone of the entire metric architecture |
| Synthetic data that doesn't match real-world distributions | 🟡 Medium | ✅ Addressed | 25 benchmark assumptions with source-backed parameters for the data generator |
| Old or outdated sources | 🟡 Medium | ✅ Addressed | KFF 2024, AMA 2025 survey, Aetna 2025-2026 press release — sources are current |
| Assumption values not labeled | 🟡 Medium | ✅ Addressed | Three assumptions clearly labeled in CSV with low-confidence flags |
| No explanation of why synthetic data is used | 🟡 Medium | ✅ Addressed | business_problem.md explicitly explains PA records are private/PHI |
| OIG sample size too small to generalize | 🟡 Medium | ✅ Acknowledged | Noted in A06: "based on 2019 study period; may have improved since" |
| Pend rates and SLA compliance rates unverifiable | 🟡 Medium | ✅ Labeled | Both carry `assumption` source IDs and low confidence levels |
| No distinction between initial denial rate and CMS appeal denial rate | 🟡 Medium | ✅ Addressed | KFF source note in S3 explains these are different measures; both included |
| Service category PA rates not benchmarked | 🟡 Medium | ⚠️ Flagged for Phase 2 | Gap identified in audit Q4 above |

---

## Audit Question 6: What Must Be Fixed Before Phase 2?

### Required Before Phase 2 Begins:

**Item 1 — Service Category PA Rate Benchmarks (Required)**
The synthetic data will include service categories (imaging, surgery, DME, inpatient, etc.). Phase 1 does not include category-level denial rates. Before generating synthetic data, research OIG service category breakdowns and/or AHIP data on PA-heavy service types to create defensible per-category denial rates.

**Item 2 — Verify OIG 2022 Report Sample Size Context (Documentation Only)**
The OIG report is based on a sample of 250 PA denials from June 1-7, 2019. When this project references the 13% inappropriate denial figure, it must always note the study scope. This is already done in the benchmark CSV (A06 notes field) but should also appear as a footnote in any dashboard or model documentation.

**Item 3 — Define Synthetic Data Schema (Required)**
The cms_metric_mapping.md identifies all data fields needed. Before coding the data generator, produce a formal data dictionary (field name, data type, allowed values, distribution assumptions, source). This becomes the Phase 2 deliverable.

### Nice-to-Have Improvements (Not Blocking):

- Add AHIP industry commitment benchmarks for PA processing times (AHIP committed to 80% real-time by 2027 — Aetna already exceeds this at 83%)
- Consider adding a state-level Medicaid PA source to enable multi-program analysis framing
- Add CMS 2026 proposed rule (CMS-0062-P) reference — this extends PA rules to drugs and would expand the project scope in a future phase

---

## Phase 1 Audit Verdict

| Deliverable | Status | Quality |
|------------|--------|---------|
| source_registry.md | ✅ Complete | 10 verified sources; full citation format; coverage map |
| business_problem.md | ✅ Complete | 6 evidence sections; 7 analytical questions; no overclaiming |
| cms_metric_mapping.md | ✅ Complete | All 5 CMS-required metrics mapped + 4 operational KPIs; data fields identified |
| public_benchmark_assumptions.csv | ✅ Complete | 25 benchmarks; all parameterized; assumptions labeled; Phase 2 ready |
| project_authenticity_check.md | ✅ Complete | This document |

**Phase 1 is complete and ready for Phase 2 (Data Architecture + Synthetic Data Generation) contingent on completing the three "Required Before Phase 2" items above.**

---

*Self-audit conducted by: Phase 1 analytics build process | Date: 2026-05-31*
